1.Establishment of 43-plex SNP Typing System and Its Forensic Application
Ya-Nan LI ; Min LI ; Lei JIANG ; Xiao-Hui LUAN ; Na LIANG ; Qian-Nan XU ; Jia-Shuo ZHANG ; Ming-Chi TANG ; Ying-Nan BIAN ; Li-Qin CHEN
Journal of Forensic Medicine 2018;34(2):126-131,137
Objective To evaluate the application of 43-plex SNP typing system in forensic science. Methods The typing of 43 SNP loci in 123 unrelated Han individuals from East China was detected by MALDI-TOF-MS. The application value of 43-plex SNP typing system was assessed according to the foren-sic parameters of population genetics. Results All the 43 SNP loci of 123 individuals showed no signifi-cant departure from Hardy-Weinberg equilibrium (P>0.05). Excepted rs1355366, rs2270529, rs10776839 and rs938283, there were 39 SNP loci had minor allele frequencies (MAF), which were greater than 0.25. Among the 25 loci MAFs, 24 ranged from 0.4 to 0.5, while 3 were close to 0.4. The DP, CDP, PIC, Ho, PEtrio and PEduo of the 43 SNP loci were 0.2901-0.6544, 1-9.8×10-11, 0.1708-0.5000, 0.1557-0.5935, 0.0854-0.2500 and 0.0146-0.1250, respectively. The CPEtrio and CPEduo were 0.999986 and 0.9924361, respectively. Conclusion The 43-plex SNP typing system in present study shows a high polymorphism, which can be an effective supplement and verification for traditional STR genetic markers. It also can be used with other commercial kits for the forensic paternity testing and individual identification.
2.Shenfu Injection alleviates sepsis-associated lung injury by regulating HIF-1α.
Luan-Luan ZHANG ; Ya-Nan ZI ; Ye-Peng ZHANG ; Hui PEI ; Xiang-Yu ZHENG ; Jia-Feng XIE ; Dong XU ; Zhi-Qiang ZHU
China Journal of Chinese Materia Medica 2023;48(23):6492-6499
Shenfu Injection(SFI) is praised for the high efficacy in the treatment of septic shock. However, the precise role of SFI in the treatment of sepsis-associated lung injury is not fully understood. This study investigated the protective effect of SFI on sepsis-associated lung injury by a clinical trial and an animal experiment focusing on the hypoxia-inducing factor-1α(HIF-1α)-mediated mitochondrial autophagy. For the clinical trial, 70 patients with sepsis-associated lung injury treated in the emergency intensive care unit of the First Affiliated Hospital of Zhengzhou University were included. The levels of interleukin(IL)-6 and tumor necrosis factor(TNF)-α were measured on days 1 and 5 for every patient. Real-time quantitative polymerase chain reaction(RT-qPCR) was performed to determine the mRNA level of hypoxia inducible factor-1α(HIF-1α) in the peripheral blood mononuclear cells(PBMCs). For the animal experiment, 32 SPF-grade male C57BL/6J mice(5-6 weeks old) were randomized into 4 groups: sham group(n=6), SFI+sham group(n=10), SFI+cecal ligation and puncture(CLP) group(n=10), and CLP group(n=6). The body weight, body temperature, wet/dry weight(W/D) ratio of the lung tissue, and the pathological injury score of the lung tissue were recorded for each mouse. RT-qPCR and Western blot were conducted to determine the expression of HIF-1α, mitochondrial DNA(mt-DNA), and autophagy-related proteins in the lung tissue. The results of the clinical trial revealed that the SFI group had lowered levels of inflammatory markers in the blood and alveolar lavage fluid and elevated level of HIF-1α in the PBMCs. The mice in the SFI group showed recovered body temperature and body weight. lowered TNF-α level in the serum, and decreased W/D ratio of the lung tissue. SFI reduced the inflammatory exudation and improved the alveolar integrity in the lung tissue. Moreover, SFI down-regulated the mtDNA expression and up-regulated the protein levels of mitochondrial transcription factor A(mt-TFA), cytochrome c oxidase Ⅳ(COXⅣ), HIF-1α, and autophagy-related proteins in the lung tissue of the model mice. The findings confirmed that SFI could promote mitophagy to improve mitochondrial function by regulating the expression of HIF-1α.
Humans
;
Male
;
Mice
;
Animals
;
Leukocytes, Mononuclear
;
Mice, Inbred C57BL
;
Lung/metabolism*
;
Acute Lung Injury/drug therapy*
;
Tumor Necrosis Factor-alpha/genetics*
;
Sepsis/genetics*
;
Hypoxia/pathology*
;
Autophagy-Related Proteins
;
Body Weight
;
Drugs, Chinese Herbal
3.Effect of Guizhitang on Atherosclerosis by Regulating Immune and Intestinal Flora
Xiao-wen YUAN ; Nan JIANG ; Dong BAI ; Bing CHEN ; Yu-mei LI ; Hui ZENG ; Ya-luan MA
Chinese Journal of Experimental Traditional Medical Formulae 2021;27(4):24-29
Objective:To observe the effect of Guizhitang (GZT) on peripheral blood monocytes, intestinal flora and AS plaque formation of ApoE-/- mice induced by Western diet (WD). Method:In this study, 40 12-week-old homozygous female ApoE-/- mice were randomly divided into chow diet (CD) group (ApoE-/-+CD), WD group (ApoE-/-+WD), GZT group (ApoE-/-+WD+GZT, 7.83 g·kg-1) and atorvastatin (Atr) group (ApoE-/-+WD+Atr, 3.33 mg·kg-1). And 10 matched C57BL/6 mice were set as wild CD control group (C57BL/6+CD). Except the CD group, the rest groups were given WD to induce models. Treatment groups were given Guizhitang or atorvastatin orally in addition to WD, while ApoE-/-+CD and ApoE-/-+WD model groups were treated with the same volume of double steam water at the same time. After 4 weeks of intervention, 5 mice in each group were selected to collect the eyeball blood samples. The levels of plasma lipids were detected by automatic biochemical analyzer, and the proportion of peripheral blood mononuclear cells and its subtypes, and the expression levels of surface receptors toll like receptor 4 (TLR4) and CD36 were detected by flow cytometry, the intestinal flora of mice was detected by 16S rDNA sequencing. The remaining 5 mice in each group were intervened for 12 weeks, and the aorta was taken to detect the formation of aortic plaque by oil red O staining. Result:After intervention for 4 week, compared with C57BL/6+CD group, the levels of plasma total cholesterol (TC) and low-density lipoprotein (LDL) levels in ApoE-/-+CD and ApoE-/-+WD groups were increased (
4.The Influence of Diabetes, Hypertension, and Hyperlipidemia on the Onset of Age-Related Macular Degeneration in North China: The Kailuan Eye Study.
Yong Peng ZHANG ; Ya Xing WANG ; Jin Qiong ZHOU ; Qian WANG ; Yan Ni YAN ; Xuan YANG ; Jing Yan YANG ; Wen Jia ZHOU ; Ping WANG ; Chang SHEN ; Ming YANG ; Ya Nan LUAN ; Jin Yuan WANG ; Shou Ling WU ; Shuo Hua CHEN ; Hai Wei WANG ; Li Jian FANG ; Qian Qian WAN ; Jing Yuan ZHU ; Zi Han NIE ; Yu Ning CHEN ; Ying XIE ; J B JONAS ; Wen Bin WEI
Biomedical and Environmental Sciences 2022;35(7):613-621
Objective:
To analyze the prevalence of dry and wet age-related macular degeneration (AMD) in patients with diabetes, hypertension and hyperlipidemia, and to analyze the risk factors for AMD.
Methods:
A population-based cross-sectional epidemiologic study was conducted involving 14,440 individuals. We assessed the prevalence of dry and wet AMD in diabetic and non-diabetic subjects and analyzed the risk factors for AMD.
Results:
The prevalence of wet AMD in diabetic and non-diabetic patients was 0.3% and 0.5%, respectively, and the prevalence of dry AMD was 17% and 16.4%, respectively. The prevalence of wet AMD in healthy, hypertensive, hyperlipidemic, and hypertensive/hyperlipidemic populations was 0.5%, 0.3%, 0.2%, and 0.7%, respectively. The prevalence of dry AMD in healthy, hypertensive, hyperlipidemic, and hypertensive/hyperlipidemic populations was 16.6%, 16.2%, 15.2%, and 17.2%, respectively. Age, sex, body mass index, and use of hypoglycemic drugs or lowering blood pressure drugs were corrected in the risk factor analysis of AMD. Diabetes, diabetes/hypertension, diabetes/hyperlipidemia, and diabetes/hypertension/hyperlipidemia were analyzed. None of the factors analyzed in the current study increased the risk for the onset of AMD.
Conclusion
There was no significant difference in the prevalence of wet and dry AMD among diabetic and non-diabetic subjects. Similarly, there was no significant difference in the prevalence of wet and dry AMD among subjects with hypertension and hyperlipidemia. Diabetes co-existing with hypertension and hyperlipidemia were not shown to be risk factors for the onset of dry AMD.
Cross-Sectional Studies
;
Diabetes Mellitus/epidemiology*
;
Humans
;
Hyperlipidemias/epidemiology*
;
Hypertension/epidemiology*
;
Macular Degeneration/etiology*
;
Risk Factors